1. Ajmani S, Jadhav K, Kulkarni SA (2006) Three-dimensional QSAR using the k-nearest neighbor method and its interpretation. J Chem Inf Model 46:24–31
2. Bezençon O, Bur D, Weller T, Richard-Bildstein S, Remen L, Sifferlen T, Corminboeuf O, Grisostomi C, Boss C, Prade L, Delahaye S, Treiber A, Strickner P, Binkert C, Hess P, Steiner B, Fischli W (2009) Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors. J Med Chem 52(12):3689–3702
3. Bhadoriya KS, Kumawat NK, Bhavthankar SV, Avchar MA, Dhuma DM, Patil SD, Jain SV (2012) Exploring 2D and 3D QSARs of benzimidazole derivatives as transient receptor potential melastatin (TRPM8) antagonists using MLR and kNN-MFA methodology. J Saudi Chem Soc. doi: 10.1016/j.jscs.2012.11.001
4. Bhadoriya KS, Sharma MC, Sharma S, Jain SV, Avchar MH (2013a) An approach to design potent anti-Alzheimer’s agents by 3D QSAR studies on fused 5,6-bicyclic heterocycles as c-secretase modulators using kNN-MFA methodology. Arab J Chem. doi: 10.1016/j.arabjc.2013.02.002
5. Bhadoriya KS, Sharma MC, Jain SV, Raut GS, Rananaware JR (2013b) Three-dimensional quantitative structure–activity relationship (3D-QSAR) analysis and molecular docking-based combined in silico rational approach to design potent and novel TRPV1 antagonists. Med Chem Res 22:2312–2327